USD 5.41 billion
Chemiluminescence Immunoassay Analyzers Market Size, Share, Growth Analysis, By Product(Fully Automated Chemiluminescence Immunoassay Analyzers and Semi-Automated Chemiluminescence Immunoassay Analyzers), By Application(Infectious Disease Testing, Endocrine System Testing, Cardiac Marker Testing, Oncology Testing), By End User(Hospitals, Diagnostic Laboratories, Research Institutes, and Point-of-Care Testing), By Region - Industry Forecast 2025-2032
Report ID:
SQMIG35H2242 |
Region:
Global |
Published Date: April, 2024
Pages:
219
|Tables:
93
|Figures:
76
Chemiluminescence Immunoassay Analyzers Market Insights
Chemiluminescence Immunoassay Analyzers Market size was valued at USD 5.82 Billion in 2023 and is poised to grow from USD 6.26 Billion in 2024 to USD 11.15 Billion by 2032, growing at a CAGR of 7.5% during the forecast period (2025-2032).
The global chemiluminescence market has been growing in recent years due to increased incidences of infectious and chronic diseases. They, however, are key in diagnostic laboratories as they exhibit high sensitivity and also specificity, being able to spot these markers linked to different health conditions.
Diseases such as infectious diseases, cardiac disorders, and cancer among others are readily diagnosed or monitored using chemiluminescence immunoassay analyzers. This creates a situation where the need for precise and fast diagnostic tools remains constant in today’s world which emphasizes on health care especially detecting diseases at the initial stages.
The market is expanding due to increasing worldwide expenditures in healthcare and growing consciousness about early diagnoses. Advanced diagnostic technologies are being adopted by private healthcare organizations, as well as governments, toward enhancing patients’ results.
Another important factor that contributes to this growth entails improvement of health care infrastructure as well as a huge demand for sophisticated diagnostics in developing countries. These analyzers are affordable and can be used in various health care facilities as well.
Some of the major players that feature in the global market are listed and they provide many chemiluminescence immunoassay analyzers with different capacity options and function. Companies have an urge to improve the performance of their products by launching innovative products such as new or better analyzers.
Market snapshot - 2024-2031
Global Market Size
Largest Segment
Fully Automated Chemiluminescence Immunoassay Analyzers
Fastest Growth
Semi-Automated Chemiluminescence Immunoassay Analyzers
Growth Rate
7.5% CAGR
Global Chemiluminescence Immunoassay Analyzer Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Chemiluminescence Immunoassay Analyzers Market Segmental Analysis
The global chemiluminescence immunoassay analyzers market is segmented into four major segments i.e. by product type, application, end user, and region. Based on type, it is divided into fully automated chemiluminescence immunoassay analyzers and semi-automated chemiluminescence immunoassay analyzers. Based on application, it is bifurcated as infectious disease testing, endocrine system testing, cardiac marker testing, oncology testing, autoimmune disease testing, allergy testing, and others. Based on end users it is segregated into hospitals, diagnostic laboratories, research institutes, and point-of-care testing. Based on region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Analysis by Type
It is anticipated that an automated fully chemiluminescence immunoassay analyzer will capture the biggest share of the market. The widespread use of this technology is driven by the need for high-speed testing, low error rates, and improved productivity in laboratories. Integration of fully automated systems into laboratory information systems is what makes these popular options in diagnostic laboratories with a high volume of tests.
The most promising type of this product may be semi-automated chemiluminescence immunoassay analysers. These analysers however offer an optimal compromise between automation and manual operations, suiting well laboratories of different testing requirements. This has made these reagents more preferable in smaller laboratories as well as sites with low testing volumes thus driving their increasing uptake in various health care set-ups.
Analysis by Application
The market is most likely to be dominated by infectious disease testing. Chemiluminescence immunoassay analyzers have seen increased uptake due to the current global focus on diagnostic of infectious diseases as part of routine testing and surveillance programs. These are very versatile analyzers that can be used for the diagnosis of different infectious diseases.
It is expected that the oncology testing sub-sector may be the most vibrant of the application segments. Increasing cases of cancer together with the development of new technology for oncology made more acute the need for reliable and sensitive diagnostics. The adoption of chemiluminescence Immunol analyzer in oncology testing is because it provides a more exact detection of cancer biomarkers. It is also worth mentioning that as attention is shifted towards early cancer detection and personalized medicine, there will be an increasing demand for analyzers in oncology applications.
Global Chemiluminescence Immunoassay Analyzer Market By Type
To get detailed analysis on other segments, Request For Free Sample Report
Chemiluminescence Immunoassay Analyzers Market Regional Insights
The region that probably will control the market is North America. It can be credited to the existing strong healthcare system, high medical expenditure, and great emphasis placed on technology enhanced diagnostics. This region has a considerable presence of main stakeholders and a number of research organisations, playing a vital role in adoption of sophisticated diagnostic technologies that make this area a leader.
The fastest growing region could be Asia Pacific. As the population increases in the area, patients become more health conscious while healthcare investments go up. All these factors lead to an increase in demand for sophisticated diagnostic solutions. Moreover, the development of the economy in Asia-Pacific countries leads to the need for advanced medical equipment such as the chemiluminescence immunoassay analyzer.
Global Chemiluminescence Immunoassay Analyzer Market By Region
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Chemiluminescence Immunoassay Analyzers Market Dynamics
Drivers
Increasing Prevalence of Chronic Diseases
- Because of this prevalence of infectious and chronic diseases, more sophisticated instruments are required for reliable and instant diagnosis. Some of those famous brands are chemiluminescence immunoassay analyzers that are commonly used in different diagnostics laboratories. The world’s focus on early detection of disease and preventive measures also helps increase the demand for these analyzers. It is the case because technological developments are of great importance and frequent improvements increase the level, accuracy, and so on.
Restraints
High Cost Associated Maintaining these Sophisticated Diagnostic Systems
- One of the main market restraints is the high cost associated with acquiring and maintaining these sophisticated diagnostic systems. The substantial initial investment may limit accessibility for smaller healthcare facilities and laboratories, impacting their ability to integrate this advanced technology. Moreover, the complexity of these analyzers and their data interpretation processes can present a learning curve for healthcare professionals, potentially affecting the speed and efficiency of diagnoses. Regulatory hurdles and compliance issues in different regions can also impede the market's expansion, requiring adherence to diverse standards and approval processes.
Request Free Customization of this report to help us to meet your business objectives.
Chemiluminescence Immunoassay Analyzers Market Competitive Landscape
There exists fierce competition in the chemiluminescence immunoassays analyzers market as different players seek for market dominance and technological leadership. The market is vibrant owing to the participation of key players such as prominent branded manufacturers and entry newcomers in the field. Companies take into account constant innovations, product development, and cooperative work with other players in order to prevail over each other. In the market, there is a wide range of chemiluminescence immunoassay analyzers that are designed differently to cater for various needs of the diagnostic laboratories and health care institutions.
Top Player’s Company Profiles
- Roche Diagnostics
- Abbott
- Siemens Healthcare
- Ortho Clinical Diagnostics
- Beckman Coulter
- Danaher (Beckman Coulter Life Sciences)
- Johnson & Johnson (Ortho-Clinical Diagnostics)
- DiaSorin
- Luminex Corporation
- Tosoh Bioscience
- Snibe Diagnostics
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- Sysmex Corporation
- Hytest Ltd.
- Bio-Rad Laboratories, Inc.
- PerkinElmer, Inc.
- ARCHITECT Diagnostics, Inc.
- Euroimmun Medizinische Labordiagnostika AG
- Mesan Pharma
- Abbott Point-of-Care Inc.
Recent Developments
- In January 2024, in a landmark event for Indian healthcare technology, Kochi-based Agappe unveiled its first indigenously manufactured HX series haematology equipment and the AE-powered Immunology CLIA (Chemiluminescence Immunoassay) analyser, the Mispa i200, marking a new era in diagnostics and patient care.
- In January 2024, Fujirebio Holdings, Inc. and Agappe Diagnostics Ltd announced that they have entered into an agreement of Contract Development and Manufacturing Organization (CDMO) partnership for Cartridge based CLIA system reagents manufacturing project for the immunology equipment Mispa i60 and Mispa i121.
Chemiluminescence Immunoassay Analyzers Key Market Trends
Rising Integration of Automation and Artificial intelligence (AI) into These Analyzers
- Automated integration of artificial intelligence (AI) in these analysers increases laboratory turnaround time and diagnostic interpretations. Besides, it facilitates tests’ administration as well as cutting down on time taken for results and increases in precision. Moreover, there is an increased interest in widening the field of use of such devices for cancer testing, screenings for microbial infections and hormone diagnostic studies. In addition, manufacturers are focusing on designing more friendly and portable analyzers aimed at addressing the growing market of PoC testing and remote diagnostics.
Chemiluminescence Immunoassay Analyzers Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
Global chemiluminescence immunoassay analyzers market analysis portrays a vibrant marketplace that comes along with some key drivers and constraints. This need has led to an increased demand for accurate, fast diagnostic solutions especially in the testing of infectious and chronic diseases. Nevertheless, high startup costs, complicated data management, and regulatory issues constrain. Fully automated analyzers take over offering high throughput tests. These also provide various testing and even customized assays with a minimum amount of effort involved. The market is dominated by developed health care infrastructure in North America. Some major trends that were reported in the industry are integrating AI for better efficiencies; however, they continue to increase medical applications, especially oncology testing, showing that the industry is pushing boundaries to advance diagnostics so as to improve patients’ outcomes.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 5.41 billion |
| Market size value in 2031 | USD 10.37 billion |
| Growth Rate | 7.5% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Chemiluminescence Immunoassay Analyzers Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Chemiluminescence Immunoassay Analyzers Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Chemiluminescence Immunoassay Analyzers Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Chemiluminescence Immunoassay Analyzers Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Chemiluminescence Immunoassay Analyzers Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Chemiluminescence Immunoassay Analyzers Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
